• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Waystar Acquires Digitize.AI to Automate Prior Authorization

Share:

July 15, 2019

By embedding this groundbreaking new technology, Waystar’s platform will take a unique approach to prior authorization using machine learning and artificial intelligence to reduce administrative work.

CHICAGO and LOUISVILLE, Ky. — July 10, 2019 — Waystar, a leading provider of revenue cycle technology today announced the acquisition of Digitize.AI, an artificial intelligence technology firm providing the healthcare industry with faster and smarter prior authorizations.

Prior authorizations, the process by which insurance companies and payers determine if they will cover a prescribed procedure or medication, are meant to help patients avoid surprise bills and unexpected out-of-network costs. But the largely manual process is time-consuming and error-prone, resulting in a $30 billion annual cost in wrongful denials, inefficiencies and clerical errors. Digitize.AI leverages the power of artificial intelligence and machine learning to automate prior authorizations, resulting in faster authorizations, at less cost, and with fewer denials.

“Providers today are overwhelmed with manual processes related to addressing prior authorization, and it’s one of our clients’ biggest challenges,” said Matt Hawkins, Waystar CEO. “Digitize.AI is taking a truly different view with trailblazing technology, automating prior authorizations with better results than legacy solutions. Together, we can reduce the stress of the healthcare financial process for providers and patients alike.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Founded in 2017, Digitize.AI differs from competitive prior authorization solutions by leveraging AI to make smarter decisions. It automatically checks for new cases, submits them directly to payers via secure integrations, continually monitors payers for responses, and, once authorization is received, automatically submits to providers’ EHR systems. Digitize.AI’s platform includes real-time analytics and machine learning models that create valuable intelligence, allowing its customers to focus on patient care instead of administrative burdens.

“We believe Digitize.AI has an enormous potential to change the industry, and we were looking for a partner who had a shared view of the ability of technology to improve healthcare,” said Justin Adams, CEO, Digitize.AI. “Waystar immediately stood out to us as a company with a forward-looking vision for simplifying the revenue cycle, as well as an established reputation and broad network of clients across the spectrum of healthcare.”

This latest acquisition in another example in a series of acquisitions that demonstrate Waystar’s commitment to prioritizing cutting-edge technology in order to provide healthcare partners with transformative solutions at scale. This past June, Waystar announced the acquisition of PARO, a charity screening predictive analytics solution, following a series of 2018 acquisitions including that of predictive analytics solution Connance and claims monitoring capabilities from UPMC’s Ovation.

Date: July 15, 2019

Source: WAySTAR

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Sanofi and TrialSpark Partner to Accelerate Tech-Driven Drug DevelopmentSanofi and TrialSpark Partner to Accelerate Tech-Driven Drug Development
  • MedAvail and MYOS RENS Technology Announce Closing of Business CombinationMedAvail and MYOS RENS Technology Announce Closing of Business Combination
  • Healthcare M&A Market Braces for a Cautiously Optimistic 2024Healthcare M&A Market Braces for a Cautiously Optimistic 2024
  • One Medical Completes Acquisition of Iora HealthOne Medical Completes Acquisition of Iora Health
  • Omada MSK by Physera Selected for Evernorth’s Digital Health FormularyOmada MSK by Physera Selected for Evernorth’s Digital Health Formulary
  • High-end marijuana retailer MedMen just spent $682 million on the largest US cannabis acquisition in historyHigh-end marijuana retailer MedMen just spent $682 million on the largest US cannabis acquisition in history
  • Exelixis and Cybrexa Therapeutics Establish Exclusive Collaboration Providing Exelixis the Right to Acquire CBX-12, a Potential First-in-class Peptide-drug Conjugate of ExatecanExelixis and Cybrexa Therapeutics Establish Exclusive Collaboration Providing Exelixis the Right to Acquire CBX-12, a Potential First-in-class Peptide-drug Conjugate of Exatecan
  • ScreenPro to Acquire Centred Ventures LLCScreenPro to Acquire Centred Ventures LLC

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications